Maria Cossu Rocca

Functional Genomics Uncover the Biology behind the Responsiveness of Head and Neck Squamous Cell Cancer Patients to Cetuximab

Paolo Bossi, Cristiana Bergamini, Marco Siano et al. · Clinical Cancer Research · 2016 · 96 citations · Full text

Medicine, Cancer Biology, Oncology +17

A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin

Paolo Bossi, Diego Cortinovis, Sonia Fatigoni et al. · Annals of Oncology · 2017 · 85 citations · Full text

Medicine, Oncology, Pharmacology +15

Retrospective analysis of factors influencing oncologic outcome in 590 patients with early‐intermediate glottic cancer treated by transoral laser microsurgery

Mohssen Ansarin, Augusto Cattaneo, Luigi De Benedetto et al. · Head & Neck · 2016 · 74 citations

Medicine, Oncology, Surgery +17

Hormone‐receptor expression and activity of trastuzumab with chemotherapy in HER2‐positive advanced breast cancer patients

Filippo Montemurro, Valentina Rossi, Maria Cossu Rocca et al. · Cancer · 2011 · 68 citations · Full text

Medicine, Oncology, Pharmacology +17

Concomitant chemoradiation (CRT) or cetuximab/RT (CET/RT) versus induction Docetaxel/ Cisplatin/5-Fluorouracil (TPF) followed by CRT or CET/RT in patients with Locally Advanced Squamous Cell Carcinoma of Head and Neck (LASCCHN). A randomized phase III factorial study (NCT01086826).

Maria Grazia Ghi, Adriano Paccagnella, Daris Ferrari et al. · Journal of Clinical Oncology · 2014 · 66 citations

Medicine, Oncology, Radiation Oncology +17